Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5084 Target Snapshot

Casein kinase I isoform gamma-3 · SINGLE PROTEIN · Homo sapiens

1,697Compounds
214Assays
2Approved Drugs
928.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9Y6M4. Use UniProt Q9Y6M4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Y6M4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Casein kinase I isoform gamma-3 as ChEMBL target CHEMBL5084, mapped to UniProt Q9Y6M4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Casein kinase I isoform gamma-3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5084
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9Y6M4
Casein kinase I isoform gamma-3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Casein kinase I isoform gamma-3 is the right protein anchor across sources, using UniProt Q9Y6M4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCasein kinase I isoform gamma-3
UniProt AccessionQ9Y6M4
Component TypeProtein
Sequence Length447 aa

Casein kinase I isoform gamma-3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Casein kinase I isoform gamma-3, mapped to UniProt Q9Y6M4. Sequence length is 447 aa.

Mapped IDQ9Y6M4
Review nameCasein kinase I isoform gamma-3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
7
Phase II
7
Phase I
Assay Mix

Activity Type Distribution

IC5023.0
KI533.0
KD372.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1999931 8.1 Ki 7.943 Preclinical
CHEMBL1965660 8.0 Ki 10.0 Preclinical
CHEMBL1969588 7.7 Ki 19.95 Preclinical
CHEMBL2003638 7.7 Ki 19.95 Preclinical
CHEMBL1990288 7.5 Ki 31.62 Preclinical
CHEMBL1981079 7.5 Ki 31.62 Preclinical
CHEMBL2006439 7.5 Ki 31.62 Preclinical
CHEMBL5434183 7.43 Kd 37.0 Preclinical
CHEMBL1996066 7.4 Ki 39.81 Preclinical
CHEMBL1966628 7.3 Ki 50.12 Preclinical
Distribution

pChEMBL Value Distribution

43
5.0
69
5.5
44
6.0
22
6.5
13
7.0
5
7.5
3
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

SUNITINIB
CHEMBL535
Approved 2006
Assay Landscape

Assay Landscape

214
Total Assays
154
Tested Compounds
2
Assay Types
Binding — 213 assays, 35 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 169 24 6.1
assay format 29 3 6.2
cell-based format 10 0
subcellular format 5 8 5.8
Functional — 1 assays, 154 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 154 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine